DEFLAMED International

DEFLAMED International is a Swiss pharmaceutical and medical device company specializing in innovative solutions for gynecology and oncology. The company's flagship product, DeflaGyn, is a vaginal gel system designed to promote the remission of abnormal cervical smears, including ASC-US, LSIL, and HSIL. By utilizing a unique combination of highly dispersed silicon dioxide and the patented antioxidant Deflamin, the product binds pathogens and neutralizes oxidative stress on the cervical surface. This non-invasive approach provides a therapeutic bridge for patients with early-stage cervical lesions, potentially delaying or preventing the need for surgical interventions like conization. DEFLAMED International operates with a focus on evidence-based medicine, supported by clinical trials demonstrating the efficacy of their delivery systems. Headquartered in Ennenda, Switzerland, the company distributes its products globally through a network of strategic pharmaceutical partners.